- Home >
- Research and Innovation >
- Technology transfer >
- Areas of expertise
Technology Transfer: our areas of expertise
Discover the range of expertise available at Institut Curie for partnerships.
Cancer biology, genetics and epigenetics
Innovating with data
Immunotherapy
Oncopediatrics
Core facilities
Translational research
Social sciences
Medical Technologies
A comprehensive, integrated medical-scientific offering
Techtransfer News
Discover all our news
Lung cancer: real-world study confirms the benefits of preoperative immunotherapy
The combination of immunotherapy and chemotherapy has become the standard neoadjuvant treatment (before surgery) for non-small cell lung cancer. This strategy was further reinforced by the final results released in 2025 from the international Phase 3 CheckMate-816 trial, coordinated by Prof. Nicolas Girard, pulmonologist and head of the department of Medical oncology at Institut Curie. A national multicenter real-world study, led by Institut Curie, now confirms the effectiveness of this strategy in routine clinical practice. These results are being presented at the European Lung Cancer Conference (ELCC), held from March 25 to 28, 2026.
26/03/2026